News Focus
News Focus
icon url

Deetew

08/07/20 4:44 PM

#68717 RE: GE_Jim #68699

CVSI should continue to offer deep discounts on their CBD products to reach as many cabinets and shelves as possible during this time. Once customers try the product, they will come back for more, because it works. Once we've established significant brand equity, and once other players are forced out of the game unable to compete with the value of our CO2 extracted product, then we gradually slow down the discounting to increase margins. Just my thoughts..
icon url

Smooth_Legend

08/08/20 2:51 AM

#68723 RE: GE_Jim #68699

I´m not worried and I don't have more to add at this time.
icon url

motorcity

08/08/20 9:58 AM

#68728 RE: GE_Jim #68699

Dowling touched on this slightly in the call. I think he said the current top players only account for 17% of the market, and the market will grow with FDA guidance while the competition will contract almost overnight, leaving 83% up for grabs theoretically with the existing good actors in the market. A vacuum that will need immediate filling.

Even if there are 10 larger companies that enter the space there should be a brief period CVSI can capitalize before others do by being on store shelves already with other products. And even once they enter if CVSI can maintain even 5% of the market that's a big number. If Brightfield is correct at the market gets to $15B, 5% is $750m, 1% is $150m.

IMO if CVSI gets in at Walmart or the like they've made their day. Everything else is gravy.